Skip to Content
Merck
  • Novel N-(phosphonomethyl) glycine derivatives: Design, characterization and biological activity.

Novel N-(phosphonomethyl) glycine derivatives: Design, characterization and biological activity.

European journal of medicinal chemistry (2007-10-24)
Emilia D Naydenova, Petar T Todorov, Margarita N Topashka-Ancheva, Georgi Ts Momekov, Tsvetelina Z Yordanova, Spiro M Konstantinov, Kolio D Troev
ABSTRACT

A series of Calpha,alpha-disubstituted cyclic derivatives of N-(phosphonomethyl) glycine have been synthesized and characterized. They exhibited moderate clastogenicity, low antiproliferative activity on mice bone marrow cells and well expressed cytotoxicity against human tumor cell lines. The 8- and 12-membered cyclic analogs proved superior to the remaining compounds and were found to trigger apoptotic cell death in DOHH-2 cells. The latter compound caused 50% inhibition of the viability of hemobastose-derived cell lines at concentrations ranging from 20 to 67 microM.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Mitomycin C from Streptomyces caespitosus, meets USP testing specifications
Sigma-Aldrich
Mitomycin C from Streptomyces caespitosus, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Mitomycin C from Streptomyces caespitosus, powder, contains NaCl as solubilizer